Peter Cicala
Board Member
Ernexa Therapeutics Inc. (ERNA)Equibles does not estimate personal net worth.
Get an email with a short summary when Ernexa Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.
Get ERNA alertsAbout Peter Cicala
Peter Cicala is recorded as Board Member at Ernexa Therapeutics Inc. (ERNA). The newest filing on record that lists Peter Cicala as Board Member at Ernexa Therapeutics Inc. (ERNA) is dated May 11, 2026. Ernexa Therapeutics Inc. reported in an 8-K filed February 16, 2024 that Peter Cicala was appointed member of the Board, effective February 12, 2024. Ernexa Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ernexa Therapeutics Inc. includes Dr. Matthew Angel (CEO), Matt Angel, Ph.D. (CEO), Sanjeev Luther (CEO and Board Member) and 7 others.
“On February 12, 2024, and effective as of that date, upon the recommendation of its Nominating and Corporate Governance Committee, the Board of Directors (the “Board”) of Eterna Therapeutics Inc. (the “Company”) appointed Mr. Peter Cicala to the Board.”
Affiliation history
-
Current
Start not stated–present
Last confirmed May 11, 2026
Company network
Leadership on record at Ernexa Therapeutics Inc.
- Dr. Matthew Angel CEO
- Matt Angel, Ph.D. CEO
- Sanjeev Luther CEO, Board Member
- Allen Wolff Chairman, Board Member
- James Bristol Chairman
- Luba Greenwood Chairman, Board Member
- Sandra Gurrola CFO
- Dorothy Clarke General Counsel
- Brant C. Binder Board Member
- Dennis H. Langer Board Member